scottbushey wrote:http://www.theheart.org/article/1036519.do
CRP is a marker of inflammation, so even if it does not cause heart disease itself, it is still possible that upstream processes have a causal role. Statins reduce CRP through their anti-inflammatory effects; so the putative benefits probably arise directly from lower inflammation rather than lower CRP.